{"transactions":[{"id":4640972,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-10-15T21:35:03.000Z","date":"2026-10-13","kind":"exercise","planned":false,"acquired":false,"shares":8333,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on October 13, 2023 with respect to 25,000 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on October 13, 2023 with respect to 25,000 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001193125-26-423056","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1682019/000119312526423056/ownership.xml","form_type":"4"}},{"id":4640971,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-10-15T21:35:03.000Z","date":"2026-10-14","kind":"sale","planned":false,"acquired":false,"shares":4098,"price":49.26,"value":201867.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":259736,"source":{"system":"sec-edgar","filing":"0001193125-26-423056","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1682019/000119312526423056/ownership.xml","form_type":"4"}},{"id":4640970,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-10-15T21:35:03.000Z","date":"2026-10-13","kind":"exercise","planned":false,"acquired":true,"shares":8333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":263834,"source":{"system":"sec-edgar","filing":"0001193125-26-423056","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682019/000119312526423056/ownership.xml","form_type":"4"}},{"id":723994,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-29T20:37:58.000Z","date":"2026-06-26","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 26, 2027 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.71,"expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001682019-26-000002","document":"form4-06292026_080654.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000168201926000002/form4-06292026_080654.xml","form_type":"4"}},{"id":727380,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2026-06-24T20:15:21.000Z","date":"2026-06-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 24, 2026, Eli Lilly and Company (\"Parent\"), through its wholly owned subsidiary LDH XV Corporation (\"Purchaser\"), acquired all outstanding Ordinary Shares of Centessa Pharmaceuticals plc (the \"Company\") by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006 (the \"Scheme of Arrangement\"), pursuant to the Transaction Agreement dated as of March 31, 2026, by and among the Company, Parent and Purchaser (the \"Transaction Agreement\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Transaction Agreement, at the effective time of the Scheme of Arrangement, each outstanding share option, whether or not vested, was automatically cancelled and converted into the right to receive (i) an amount in cash equal to the excess of $38.00 in cash over the per-share exercise price of such option, without interest and less any applicable withholding taxes, and (ii) one non-transferable contingent value right (a \"CVR\") per underlying Ordinary Share entitling the holders to receive contingent payments of up to an aggregate of $9.00 per Ordinary Share, without interest and less any applicable withholding taxes, contingent upon the achievement of specified milestones set forth in the Contingent Value Rights Agreement between Parent, Purchaser and a rights agent mutually agreeable to the Company and Parent, in each case in accordance with the Transaction Agreement. No share options were exercised prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Transaction Agreement, at the effective time of the Scheme of Arrangement, each outstanding share option, whether or not vested, was automatically cancelled and converted into the right to receive (i) an amount in cash equal to the excess of $38.00 in cash over the per-share exercise price of such option, without interest and less any applicable withholding taxes, and (ii) one non-transferable contingent value right (a \"CVR\") per underlying Ordinary Share entitling the holders to receive contingent payments of up to an aggregate of $9.00 per Ordinary Share, without interest and less any applicable withholding taxes, contingent upon the achievement of specified milestones set forth in the Contingent Value Rights Agreement between Parent, Purchaser and a rights agent mutually agreeable to the Company and Parent, in each case in accordance with the Transaction Agreement. No share options were exercised prior to the Effective Time."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"exercise_price":12.43,"expiration_date":"2035-06-20","underlying":"Ordinary Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001470831-26-000608","document":"wk-form4_1782332111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1682019/000147083126000608/wk-form4_1782332111.xml","form_type":"4"}},{"id":727379,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2026-06-24T20:15:21.000Z","date":"2026-06-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":48000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 24, 2026, Eli Lilly and Company (\"Parent\"), through its wholly owned subsidiary LDH XV Corporation (\"Purchaser\"), acquired all outstanding Ordinary Shares of Centessa Pharmaceuticals plc (the \"Company\") by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006 (the \"Scheme of Arrangement\"), pursuant to the Transaction Agreement dated as of March 31, 2026, by and among the Company, Parent and Purchaser (the \"Transaction Agreement\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Transaction Agreement, at the effective time of the Scheme of Arrangement, each outstanding share option, whether or not vested, was automatically cancelled and converted into the right to receive (i) an amount in cash equal to the excess of $38.00 in cash over the per-share exercise price of such option, without interest and less any applicable withholding taxes, and (ii) one non-transferable contingent value right (a \"CVR\") per underlying Ordinary Share entitling the holders to receive contingent payments of up to an aggregate of $9.00 per Ordinary Share, without interest and less any applicable withholding taxes, contingent upon the achievement of specified milestones set forth in the Contingent Value Rights Agreement between Parent, Purchaser and a rights agent mutually agreeable to the Company and Parent, in each case in accordance with the Transaction Agreement. No share options were exercised prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Transaction Agreement, at the effective time of the Scheme of Arrangement, each outstanding share option, whether or not vested, was automatically cancelled and converted into the right to receive (i) an amount in cash equal to the excess of $38.00 in cash over the per-share exercise price of such option, without interest and less any applicable withholding taxes, and (ii) one non-transferable contingent value right (a \"CVR\") per underlying Ordinary Share entitling the holders to receive contingent payments of up to an aggregate of $9.00 per Ordinary Share, without interest and less any applicable withholding taxes, contingent upon the achievement of specified milestones set forth in the Contingent Value Rights Agreement between Parent, Purchaser and a rights agent mutually agreeable to the Company and Parent, in each case in accordance with the Transaction Agreement. No share options were exercised prior to the Effective Time."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"exercise_price":8.89,"expiration_date":"2034-06-25","underlying":"Ordinary Shares","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001470831-26-000608","document":"wk-form4_1782332111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1682019/000147083126000608/wk-form4_1782332111.xml","form_type":"4"}},{"id":727378,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2026-06-24T20:15:21.000Z","date":"2026-06-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":48000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 24, 2026, Eli Lilly and Company (\"Parent\"), through its wholly owned subsidiary LDH XV Corporation (\"Purchaser\"), acquired all outstanding Ordinary Shares of Centessa Pharmaceuticals plc (the \"Company\") by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006 (the \"Scheme of Arrangement\"), pursuant to the Transaction Agreement dated as of March 31, 2026, by and among the Company, Parent and Purchaser (the \"Transaction Agreement\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Transaction Agreement, at the effective time of the Scheme of Arrangement, each outstanding share option, whether or not vested, was automatically cancelled and converted into the right to receive (i) an amount in cash equal to the excess of $38.00 in cash over the per-share exercise price of such option, without interest and less any applicable withholding taxes, and (ii) one non-transferable contingent value right (a \"CVR\") per underlying Ordinary Share entitling the holders to receive contingent payments of up to an aggregate of $9.00 per Ordinary Share, without interest and less any applicable withholding taxes, contingent upon the achievement of specified milestones set forth in the Contingent Value Rights Agreement between Parent, Purchaser and a rights agent mutually agreeable to the Company and Parent, in each case in accordance with the Transaction Agreement. No share options were exercised prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Transaction Agreement, at the effective time of the Scheme of Arrangement, each outstanding share option, whether or not vested, was automatically cancelled and converted into the right to receive (i) an amount in cash equal to the excess of $38.00 in cash over the per-share exercise price of such option, without interest and less any applicable withholding taxes, and (ii) one non-transferable contingent value right (a \"CVR\") per underlying Ordinary Share entitling the holders to receive contingent payments of up to an aggregate of $9.00 per Ordinary Share, without interest and less any applicable withholding taxes, contingent upon the achievement of specified milestones set forth in the Contingent Value Rights Agreement between Parent, Purchaser and a rights agent mutually agreeable to the Company and Parent, in each case in accordance with the Transaction Agreement. No share options were exercised prior to the Effective Time."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"exercise_price":6.35,"expiration_date":"2033-06-22","underlying":"Ordinary Shares","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001470831-26-000608","document":"wk-form4_1782332111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1682019/000147083126000608/wk-form4_1782332111.xml","form_type":"4"}},{"id":727377,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2026-06-24T20:15:21.000Z","date":"2026-06-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":48000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 24, 2026, Eli Lilly and Company (\"Parent\"), through its wholly owned subsidiary LDH XV Corporation (\"Purchaser\"), acquired all outstanding Ordinary Shares of Centessa Pharmaceuticals plc (the \"Company\") by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006 (the \"Scheme of Arrangement\"), pursuant to the Transaction Agreement dated as of March 31, 2026, by and among the Company, Parent and Purchaser (the \"Transaction Agreement\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Transaction Agreement, at the effective time of the Scheme of Arrangement, each outstanding share option, whether or not vested, was automatically cancelled and converted into the right to receive (i) an amount in cash equal to the excess of $38.00 in cash over the per-share exercise price of such option, without interest and less any applicable withholding taxes, and (ii) one non-transferable contingent value right (a \"CVR\") per underlying Ordinary Share entitling the holders to receive contingent payments of up to an aggregate of $9.00 per Ordinary Share, without interest and less any applicable withholding taxes, contingent upon the achievement of specified milestones set forth in the Contingent Value Rights Agreement between Parent, Purchaser and a rights agent mutually agreeable to the Company and Parent, in each case in accordance with the Transaction Agreement. No share options were exercised prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Transaction Agreement, at the effective time of the Scheme of Arrangement, each outstanding share option, whether or not vested, was automatically cancelled and converted into the right to receive (i) an amount in cash equal to the excess of $38.00 in cash over the per-share exercise price of such option, without interest and less any applicable withholding taxes, and (ii) one non-transferable contingent value right (a \"CVR\") per underlying Ordinary Share entitling the holders to receive contingent payments of up to an aggregate of $9.00 per Ordinary Share, without interest and less any applicable withholding taxes, contingent upon the achievement of specified milestones set forth in the Contingent Value Rights Agreement between Parent, Purchaser and a rights agent mutually agreeable to the Company and Parent, in each case in accordance with the Transaction Agreement. No share options were exercised prior to the Effective Time."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"exercise_price":4.87,"expiration_date":"2032-06-30","underlying":"Ordinary Shares","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001470831-26-000608","document":"wk-form4_1782332111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1682019/000147083126000608/wk-form4_1782332111.xml","form_type":"4"}},{"id":727376,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2026-06-24T20:15:21.000Z","date":"2026-06-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":208474,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 24, 2026, Eli Lilly and Company (\"Parent\"), through its wholly owned subsidiary LDH XV Corporation (\"Purchaser\"), acquired all outstanding Ordinary Shares of Centessa Pharmaceuticals plc (the \"Company\") by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006 (the \"Scheme of Arrangement\"), pursuant to the Transaction Agreement dated as of March 31, 2026, by and among the Company, Parent and Purchaser (the \"Transaction Agreement\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Transaction Agreement, at the effective time of the Scheme of Arrangement, each outstanding share option, whether or not vested, was automatically cancelled and converted into the right to receive (i) an amount in cash equal to the excess of $38.00 in cash over the per-share exercise price of such option, without interest and less any applicable withholding taxes, and (ii) one non-transferable contingent value right (a \"CVR\") per underlying Ordinary Share entitling the holders to receive contingent payments of up to an aggregate of $9.00 per Ordinary Share, without interest and less any applicable withholding taxes, contingent upon the achievement of specified milestones set forth in the Contingent Value Rights Agreement between Parent, Purchaser and a rights agent mutually agreeable to the Company and Parent, in each case in accordance with the Transaction Agreement. No share options were exercised prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Transaction Agreement, at the effective time of the Scheme of Arrangement, each outstanding share option, whether or not vested, was automatically cancelled and converted into the right to receive (i) an amount in cash equal to the excess of $38.00 in cash over the per-share exercise price of such option, without interest and less any applicable withholding taxes, and (ii) one non-transferable contingent value right (a \"CVR\") per underlying Ordinary Share entitling the holders to receive contingent payments of up to an aggregate of $9.00 per Ordinary Share, without interest and less any applicable withholding taxes, contingent upon the achievement of specified milestones set forth in the Contingent Value Rights Agreement between Parent, Purchaser and a rights agent mutually agreeable to the Company and Parent, in each case in accordance with the Transaction Agreement. No share options were exercised prior to the Effective Time."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"exercise_price":5.84,"expiration_date":"2031-02-19","underlying":"Ordinary Shares","underlying_shares":208474},"source":{"system":"sec-edgar","filing":"0001470831-26-000608","document":"wk-form4_1782332111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682019/000147083126000608/wk-form4_1782332111.xml","form_type":"4"}},{"id":753112,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-03T20:50:58.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":9136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/12 of the underlying shares monthly from June 2, 2026."}],"balance_after":9136,"derivative":{"exercise_price":55.23,"expiration_date":"2036-06-01","underlying":"Common Stock","underlying_shares":9136},"source":{"system":"sec-edgar","filing":"0000907654-26-000051","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000051/form4.xml","form_type":"4"}},{"id":829315,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-24T21:37:54.000Z","date":"2026-03-20","kind":"exercise","planned":false,"acquired":false,"shares":19687,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 78,750 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 78,750 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."}],"balance_after":39375,"derivative":{"underlying":"Common Shares","underlying_shares":19687},"source":{"system":"sec-edgar","filing":"0001193125-26-122272","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122272/ownership.xml","form_type":"4"}},{"id":829314,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-24T21:37:54.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":81875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This restricted stock unit award was granted on March 20, 2026 with respect to 81,875 Common Shares, with (i) one quarter of the shares vesting on March 20, 2027 , (ii) one quarter of the shares vesting on March 20, 2028, (iii) one quarter of the shares vesting on March 20, 2029, and (iv) one quarter of the shares vesting on March 20, 2030."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This restricted stock unit award was granted on March 20, 2026 with respect to 81,875 Common Shares, with (i) one quarter of the shares vesting on March 20, 2027 , (ii) one quarter of the shares vesting on March 20, 2028, (iii) one quarter of the shares vesting on March 20, 2029, and (iv) one quarter of the shares vesting on March 20, 2030."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This restricted stock unit award was granted on March 20, 2026 with respect to 81,875 Common Shares, with (i) one quarter of the shares vesting on March 20, 2027 , (ii) one quarter of the shares vesting on March 20, 2028, (iii) one quarter of the shares vesting on March 20, 2029, and (iv) one quarter of the shares vesting on March 20, 2030."}],"balance_after":81875,"derivative":{"underlying":"Common Shares","underlying_shares":81875},"source":{"system":"sec-edgar","filing":"0001193125-26-122272","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122272/ownership.xml","form_type":"4"}},{"id":829313,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-24T21:37:54.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":114249,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on March 20, 2026 with respect to 114,249 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 20, 2026."}],"balance_after":114249,"derivative":{"exercise_price":46.24,"expiration_date":"2036-03-20","underlying":"Common Shares","underlying_shares":114249},"source":{"system":"sec-edgar","filing":"0001193125-26-122272","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122272/ownership.xml","form_type":"4"}},{"id":829312,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-24T21:37:54.000Z","date":"2026-03-23","kind":"sale","planned":false,"acquired":false,"shares":10020,"price":46.78,"value":468735.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":255501,"source":{"system":"sec-edgar","filing":"0001193125-26-122272","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122272/ownership.xml","form_type":"4"}},{"id":829311,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-24T21:37:54.000Z","date":"2026-03-20","kind":"exercise","planned":false,"acquired":true,"shares":19687,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":265521,"source":{"system":"sec-edgar","filing":"0001193125-26-122272","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122272/ownership.xml","form_type":"4"}},{"id":837946,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:35:20.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":false,"shares":20625,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 82,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 82,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."}],"balance_after":61875,"derivative":{"underlying":"Common Shares","underlying_shares":20625},"source":{"system":"sec-edgar","filing":"0001193125-26-111278","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111278/ownership.xml","form_type":"4"}},{"id":837945,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-17T21:35:20.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":10349,"price":48.26,"value":499442.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":245834,"source":{"system":"sec-edgar","filing":"0001193125-26-111278","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111278/ownership.xml","form_type":"4"}},{"id":837944,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-17T21:35:20.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":true,"shares":20625,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":256183,"source":{"system":"sec-edgar","filing":"0001193125-26-111278","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111278/ownership.xml","form_type":"4"}},{"id":846102,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-12T21:35:04.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":false,"shares":19250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on March 10, 2023 with respect to 77,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on March 10, 2023 with respect to 77,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027."}],"balance_after":19250,"derivative":{"underlying":"Common Shares","underlying_shares":19250},"source":{"system":"sec-edgar","filing":"0001193125-26-104480","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526104480/ownership.xml","form_type":"4"}},{"id":846101,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-12T21:35:04.000Z","date":"2026-03-11","kind":"sale","planned":false,"acquired":false,"shares":9798,"price":52.8,"value":517334.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":235558,"source":{"system":"sec-edgar","filing":"0001193125-26-104480","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526104480/ownership.xml","form_type":"4"}},{"id":846100,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-03-12T21:35:04.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":true,"shares":19250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":245356,"source":{"system":"sec-edgar","filing":"0001193125-26-104480","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526104480/ownership.xml","form_type":"4"}},{"id":890703,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-20T22:36:52.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":false,"shares":13250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 53,000 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 53,000 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":13250},"source":{"system":"sec-edgar","filing":"0001193125-26-061712","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526061712/ownership.xml","form_type":"4"}},{"id":890702,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-02-20T22:36:52.000Z","date":"2026-02-19","kind":"sale","planned":false,"acquired":false,"shares":6967,"price":52.58,"value":366324.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":226106,"source":{"system":"sec-edgar","filing":"0001193125-26-061712","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526061712/ownership.xml","form_type":"4"}},{"id":890701,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-02-20T22:36:52.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":true,"shares":13250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects 85,622 shares previously transferred from the Kulkarni 2023 GRAT to the Reporting Person."}],"balance_after":233073,"source":{"system":"sec-edgar","filing":"0001193125-26-061712","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526061712/ownership.xml","form_type":"4"}},{"id":933413,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-01-22T22:55:02.000Z","date":"2026-01-22","kind":"sale","planned":true,"acquired":false,"shares":60000,"price":60.23,"value":3613800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.61, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":134201,"source":{"system":"sec-edgar","filing":"0001193125-26-019733","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526019733/ownership.xml","form_type":"4"}},{"id":933412,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-01-22T22:55:02.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":8567,"price":52.1,"value":446340.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.00 to $52.45 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":194201,"source":{"system":"sec-edgar","filing":"0001193125-26-019733","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526019733/ownership.xml","form_type":"4"}},{"id":933411,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-01-22T22:55:02.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":21433,"price":51.61,"value":1106157.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.00 to $51.99, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":202768,"source":{"system":"sec-edgar","filing":"0001193125-26-019733","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526019733/ownership.xml","form_type":"4"}},{"id":960991,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-12-22T22:35:04.000Z","date":"2025-12-18","kind":"gift","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":224201,"source":{"system":"sec-edgar","filing":"0001193125-25-329010","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525329010/ownership.xml","form_type":"4"}},{"id":1015854,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-20T21:35:03.000Z","date":"2025-10-16","kind":"exercise","planned":false,"acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on October 16, 2024 with respect to 400,000 Common Shares, with (i) one quarter of the shares vesting on October 16, 2025, (ii) one quarter of the shares vesting on October 16, 2026, (iii) one quarter of the shares vesting on October 16, 2027, and (iv) one quarter of the shares vesting on October 16, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on October 16, 2024 with respect to 400,000 Common Shares, with (i) one quarter of the shares vesting on October 16, 2025, (ii) one quarter of the shares vesting on October 16, 2026, (iii) one quarter of the shares vesting on October 16, 2027, and (iv) one quarter of the shares vesting on October 16, 2028."}],"balance_after":300000,"derivative":{"underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193125-25-243819","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525243819/ownership.xml","form_type":"4"}},{"id":1015853,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-10-20T21:35:03.000Z","date":"2025-10-17","kind":"sale","planned":false,"acquired":false,"shares":50895,"price":67.91,"value":3456279.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":254201,"source":{"system":"sec-edgar","filing":"0001193125-25-243819","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525243819/ownership.xml","form_type":"4"}},{"id":1015852,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-10-20T21:35:03.000Z","date":"2025-10-16","kind":"exercise","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":305096,"source":{"system":"sec-edgar","filing":"0001193125-25-243819","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525243819/ownership.xml","form_type":"4"}},{"id":1018463,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-15T21:35:05.000Z","date":"2025-10-13","kind":"exercise","planned":false,"acquired":false,"shares":8334,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on October 13, 2023 with respect to 25,000 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on October 13, 2023 with respect to 25,000 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026."}],"balance_after":8333,"derivative":{"underlying":"Common Shares","underlying_shares":8334},"source":{"system":"sec-edgar","filing":"0001193125-25-240438","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525240438/ownership.xml","form_type":"4"}},{"id":1018462,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-10-15T21:35:05.000Z","date":"2025-10-14","kind":"sale","planned":false,"acquired":false,"shares":4242,"price":66.6,"value":282517.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":205096,"source":{"system":"sec-edgar","filing":"0001193125-25-240438","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525240438/ownership.xml","form_type":"4"}},{"id":1018461,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-10-15T21:35:05.000Z","date":"2025-10-13","kind":"exercise","planned":false,"acquired":true,"shares":8334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":209338,"source":{"system":"sec-edgar","filing":"0001193125-25-240438","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525240438/ownership.xml","form_type":"4"}},{"id":1024574,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-03T21:38:21.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":49500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on October 3, 2025 with respect to 49,500 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 3, 2025."}],"balance_after":49500,"derivative":{"exercise_price":67.74,"expiration_date":"2035-10-03","underlying":"Common Shares","underlying_shares":49500},"source":{"system":"sec-edgar","filing":"0001193125-25-230511","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525230511/ownership.xml","form_type":"4"}},{"id":1035551,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-09-19T21:42:39.000Z","date":"2025-09-17","kind":"gift","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person made a charitable contribution of common shares to a donor advised fund."}],"balance_after":201004,"source":{"system":"sec-edgar","filing":"0001193125-25-209353","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525209353/ownership.xml","form_type":"4"}},{"id":1061876,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-08-19T20:30:20.000Z","date":"2025-08-16","kind":"exercise","planned":false,"acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on August 16, 2022 with respect to 25,000 Common Shares, with 100% of the shares vesting on August 16, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on August 16, 2022 with respect to 25,000 Common Shares, with 100% of the shares vesting on August 16, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001682019-25-000003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000168201925000003/ownership.xml","form_type":"4"}},{"id":1061875,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-08-19T20:30:20.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":13081,"price":58.15,"value":760660.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":207004,"source":{"system":"sec-edgar","filing":"0001682019-25-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000168201925000003/ownership.xml","form_type":"4"}},{"id":1061874,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-08-19T20:30:20.000Z","date":"2025-08-16","kind":"exercise","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":220085,"source":{"system":"sec-edgar","filing":"0001682019-25-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000168201925000003/ownership.xml","form_type":"4"}},{"id":1102334,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2025-06-24T20:11:54.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option will vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of shareholders, subject to continued service as a director through the applicable vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":40000,"derivative":{"exercise_price":12.43,"expiration_date":"2035-06-20","underlying":"Ordinary Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001847903-25-000106","document":"wk-form4_1750795907.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682019/000184790325000106/wk-form4_1750795907.xml","form_type":"4"}},{"id":1113453,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T22:22:19.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":30550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 12, 2026 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":30550,"derivative":{"exercise_price":2.43,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":30550},"source":{"system":"sec-edgar","filing":"0001415889-25-017048","document":"form4-06122025_100615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000141588925017048/form4-06122025_100615.xml","form_type":"4"}},{"id":1126286,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-03T20:14:17.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/12 of the underlying shares monthly from June 2, 2025."}],"balance_after":17500,"derivative":{"exercise_price":11.77,"expiration_date":"2035-06-01","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001062993-25-010826","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000106299325010826/form4.xml","form_type":"4"}},{"id":1193478,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-24T21:35:09.000Z","date":"2025-03-20","kind":"exercise","planned":false,"acquired":false,"shares":19688,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 78,750 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 78,750 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."}],"balance_after":59062,"derivative":{"underlying":"Common Shares","underlying_shares":19688},"source":{"system":"sec-edgar","filing":"0000950170-25-043975","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025043975/ownership.xml","form_type":"4"}},{"id":1193477,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-03-24T21:35:09.000Z","date":"2025-03-21","kind":"sale","planned":false,"acquired":false,"shares":10031,"price":41.23,"value":413578.13,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":195085,"source":{"system":"sec-edgar","filing":"0000950170-25-043975","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025043975/ownership.xml","form_type":"4"}},{"id":1193476,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-03-24T21:35:09.000Z","date":"2025-03-20","kind":"exercise","planned":false,"acquired":true,"shares":19688,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":205116,"source":{"system":"sec-edgar","filing":"0000950170-25-043975","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025043975/ownership.xml","form_type":"4"}},{"id":1199815,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-18T21:35:07.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":82500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 82,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 82,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."}],"balance_after":82500,"derivative":{"underlying":"Common Shares","underlying_shares":82500},"source":{"system":"sec-edgar","filing":"0000950170-25-041469","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025041469/ownership.xml","form_type":"4"}},{"id":1199814,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-18T21:35:07.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 14, 2025 with respect to 110,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 14, 2025."}],"balance_after":110000,"derivative":{"exercise_price":42.12,"expiration_date":"2035-03-14","underlying":"Common Shares","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0000950170-25-041469","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025041469/ownership.xml","form_type":"4"}},{"id":1209624,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-12T23:05:06.000Z","date":"2025-03-11","kind":"exercise","planned":false,"acquired":false,"shares":9000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on March 11, 2021 with respect to 36,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on March 11, 2021 with respect to 36,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000950170-25-038216","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025038216/ownership.xml","form_type":"4"}},{"id":1209623,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-12T23:05:06.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":19250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on March 10, 2023 with respect to 77,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on March 10, 2023 with respect to 77,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027."}],"balance_after":38500,"derivative":{"underlying":"Common Shares","underlying_shares":19250},"source":{"system":"sec-edgar","filing":"0000950170-25-038216","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025038216/ownership.xml","form_type":"4"}},{"id":1209622,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-03-12T23:05:06.000Z","date":"2025-03-12","kind":"sale","planned":false,"acquired":false,"shares":4462,"price":43.32,"value":193293.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":185428,"source":{"system":"sec-edgar","filing":"0000950170-25-038216","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025038216/ownership.xml","form_type":"4"}},{"id":1209621,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-03-12T23:05:06.000Z","date":"2025-03-11","kind":"exercise","planned":false,"acquired":true,"shares":9000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":189890,"source":{"system":"sec-edgar","filing":"0000950170-25-038216","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025038216/ownership.xml","form_type":"4"}},{"id":1209620,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-03-12T23:05:06.000Z","date":"2025-03-11","kind":"sale","planned":false,"acquired":false,"shares":9973,"price":42.42,"value":423054.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":180890,"source":{"system":"sec-edgar","filing":"0000950170-25-038216","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025038216/ownership.xml","form_type":"4"}},{"id":1209619,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-03-12T23:05:06.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":19250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":190863,"source":{"system":"sec-edgar","filing":"0000950170-25-038216","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025038216/ownership.xml","form_type":"4"}},{"id":1252958,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-02-21T22:35:06.000Z","date":"2025-02-19","kind":"sale","planned":true,"acquired":false,"shares":18360,"price":55.205,"value":1013563.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $55.02 to $55.46, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":171613,"source":{"system":"sec-edgar","filing":"0000950170-25-025000","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025025000/ownership.xml","form_type":"4"}},{"id":1259981,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-19T22:35:05.000Z","date":"2025-02-18","kind":"exercise","planned":true,"acquired":false,"shares":13250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 53,000 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 53,000 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."}],"balance_after":13250,"derivative":{"underlying":"Common Shares","underlying_shares":13250},"source":{"system":"sec-edgar","filing":"0000950170-25-023385","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025023385/ownership.xml","form_type":"4"}},{"id":1259980,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-02-19T22:35:05.000Z","date":"2025-02-19","kind":"sale","planned":true,"acquired":false,"shares":6928,"price":52.8,"value":365798.4,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":189973,"source":{"system":"sec-edgar","filing":"0000950170-25-023385","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025023385/ownership.xml","form_type":"4"}},{"id":1259979,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-02-19T22:35:05.000Z","date":"2025-02-18","kind":"sale","planned":true,"acquired":false,"shares":11640,"price":55.05,"value":640782.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.2850, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of\nthe Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":196901,"source":{"system":"sec-edgar","filing":"0000950170-25-023385","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025023385/ownership.xml","form_type":"4"}},{"id":1259978,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-02-19T22:35:05.000Z","date":"2025-02-18","kind":"exercise","planned":true,"acquired":true,"shares":13250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":208541,"source":{"system":"sec-edgar","filing":"0000950170-25-023385","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025023385/ownership.xml","form_type":"4"}},{"id":1320963,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-27T22:35:04.000Z","date":"2024-12-24","kind":"exercise","planned":false,"acquired":false,"shares":13751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 3, 2017 with respect to 100,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning May 31, 2017."}],"balance_after":0,"derivative":{"exercise_price":16.21,"expiration_date":"2027-05-03","underlying":"Common Shares","underlying_shares":13751},"source":{"system":"sec-edgar","filing":"0000950170-24-140846","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024140846/ownership.xml","form_type":"4"}},{"id":1320962,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-12-27T22:35:04.000Z","date":"2024-12-24","kind":"exercise","planned":false,"acquired":true,"shares":13751,"price":16.21,"value":222903.71,"ownership":{"direct":true},"balance_after":195291,"source":{"system":"sec-edgar","filing":"0000950170-24-140846","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024140846/ownership.xml","form_type":"4"}},{"id":1342950,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-12-04T22:35:03.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":55.1043,"value":826564.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of\nthe Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":181540,"source":{"system":"sec-edgar","filing":"0000950170-24-133373","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024133373/ownership.xml","form_type":"4"}},{"id":1366573,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-11-13T22:35:03.000Z","date":"2024-11-11","kind":"sale","planned":true,"acquired":false,"shares":6879,"price":56.27,"value":387081.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.00 to $56.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":196540,"source":{"system":"sec-edgar","filing":"0000950170-24-126521","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024126521/ownership.xml","form_type":"4"}},{"id":1366572,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-11-13T22:35:03.000Z","date":"2024-11-11","kind":"sale","planned":true,"acquired":false,"shares":23121,"price":55.43,"value":1281597.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 to $55.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":203419,"source":{"system":"sec-edgar","filing":"0000950170-24-126521","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024126521/ownership.xml","form_type":"4"}},{"id":1384105,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-10-18T21:35:04.000Z","date":"2024-10-16","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on October 16, 2024 with respect to 400,000 Common Shares, with (i) one quarter of the shares vesting on October 16, 2025, (ii) one quarter of the shares vesting on October 16, 2026, (iii) one quarter of the shares vesting on October 16, 2027, and (iv) one quarter of the shares vesting on October 16, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on October 16, 2024 with respect to 400,000 Common Shares, with (i) one quarter of the shares vesting on October 16, 2025, (ii) one quarter of the shares vesting on October 16, 2026, (iii) one quarter of the shares vesting on October 16, 2027, and (iv) one quarter of the shares vesting on October 16, 2028."}],"balance_after":400000,"derivative":{"underlying":"Common Shares","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0000950170-24-115694","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024115694/ownership.xml","form_type":"4"}},{"id":1384104,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-18T21:35:04.000Z","date":"2024-10-16","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on October 16, 2024 with respect to 55,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 16, 2024."}],"balance_after":55000,"derivative":{"exercise_price":49,"expiration_date":"2034-10-16","underlying":"Common Shares","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0000950170-24-115694","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024115694/ownership.xml","form_type":"4"}},{"id":1386697,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-10-15T22:00:04.000Z","date":"2024-10-13","kind":"exercise","planned":false,"acquired":false,"shares":8333,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on October 13, 2023 with respect to 25,000 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on October 13, 2023 with respect to 25,000 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026."}],"balance_after":16667,"derivative":{"underlying":"Common Shares","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0000950170-24-114786","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024114786/ownership.xml","form_type":"4"}},{"id":1386696,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-10-15T22:00:04.000Z","date":"2024-10-14","kind":"sale","planned":false,"acquired":false,"shares":4293,"price":46.28,"value":198680.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":226540,"source":{"system":"sec-edgar","filing":"0000950170-24-114786","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024114786/ownership.xml","form_type":"4"}},{"id":1386695,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-10-15T22:00:04.000Z","date":"2024-10-13","kind":"exercise","planned":false,"acquired":true,"shares":8333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":230833,"source":{"system":"sec-edgar","filing":"0000950170-24-114786","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024114786/ownership.xml","form_type":"4"}},{"id":1435998,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-08-12T22:45:42.000Z","date":"2024-08-08","kind":"gift","planned":false,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects 114,378 shares previously transferred from the Kulkarni 2023 GRAT to the Reporting Person."}],"balance_after":222500,"source":{"system":"sec-edgar","filing":"0000950170-24-095615","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024095615/ownership.xml","form_type":"4"}},{"id":1467935,"issuer":{"id":35581,"kind":"organization","name":"Centessa Pharmaceuticals plc","symbol":"CNTA"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2024-06-27T20:32:22.000Z","date":"2024-06-25","kind":"grant","planned":false,"acquired":true,"shares":48000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option will vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of shareholders, subject to continued service as a director through the applicable vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":48000,"derivative":{"exercise_price":8.89,"expiration_date":"2034-06-25","underlying":"Ordinary Shares","underlying_shares":48000},"source":{"system":"sec-edgar","filing":"0001847903-24-000104","document":"wk-form4_1719520334.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682019/000184790324000104/wk-form4_1719520334.xml","form_type":"4"}},{"id":1473301,"issuer":{"id":68433,"kind":"organization","name":"Repare Therapeutics Inc.","symbol":"RPTX"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-20T20:35:12.000Z","date":"2024-06-17","kind":"grant","planned":false,"acquired":true,"shares":27200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over twelve (12) months from the date of grant, subject to Reporting Person continuing to provide service through each such date."}],"balance_after":27200,"derivative":{"exercise_price":3.8,"expiration_date":"2034-06-16","underlying":"Common Shares","underlying_shares":27200},"source":{"system":"sec-edgar","filing":"0001415889-24-017656","document":"form4-06202024_040608.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808158/000141588924017656/form4-06202024_040608.xml","form_type":"4"}},{"id":1488472,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T21:55:15.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":30550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) June 6, 2025 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":30550,"derivative":{"exercise_price":4.65,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":30550},"source":{"system":"sec-edgar","filing":"0001415889-24-015828","document":"form4-06062024_090611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1701541/000141588924015828/form4-06062024_090611.xml","form_type":"4"}},{"id":1539999,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-17T21:45:06.000Z","date":"2024-04-15","kind":"exercise","planned":true,"acquired":false,"shares":19582,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on December 1, 2017 with respect to 260,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning January 1, 2018."}],"balance_after":0,"derivative":{"exercise_price":19.12,"expiration_date":"2027-12-01","underlying":"Common Shares","underlying_shares":19582},"source":{"system":"sec-edgar","filing":"0000950170-24-045196","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024045196/ownership.xml","form_type":"4"}},{"id":1539998,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-04-17T21:45:06.000Z","date":"2024-04-15","kind":"sale","planned":true,"acquired":false,"shares":1204,"price":60.4003,"value":72721.9612,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.36 to $60.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":208122,"source":{"system":"sec-edgar","filing":"0000950170-24-045196","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024045196/ownership.xml","form_type":"4"}},{"id":1539997,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-04-17T21:45:06.000Z","date":"2024-04-15","kind":"sale","planned":true,"acquired":false,"shares":18378,"price":59.8819,"value":1100509.5582,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.355 to $60.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":209326,"source":{"system":"sec-edgar","filing":"0000950170-24-045196","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024045196/ownership.xml","form_type":"4"}},{"id":1539996,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-04-17T21:45:06.000Z","date":"2024-04-15","kind":"exercise","planned":true,"acquired":true,"shares":19582,"price":19.12,"value":374407.84,"ownership":{"direct":true},"balance_after":227704,"source":{"system":"sec-edgar","filing":"0000950170-24-045196","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024045196/ownership.xml","form_type":"4"}},{"id":1563385,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-22T21:45:03.000Z","date":"2024-03-20","kind":"grant","planned":false,"acquired":true,"shares":78750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 78,750 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 78,750 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."}],"balance_after":78750,"derivative":{"underlying":"Common Shares","underlying_shares":78750},"source":{"system":"sec-edgar","filing":"0000950170-24-035515","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024035515/ownership.xml","form_type":"4"}},{"id":1563384,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-22T21:45:03.000Z","date":"2024-03-20","kind":"grant","planned":false,"acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 20, 2024 with respect to 105,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 20, 2024."}],"balance_after":105000,"derivative":{"exercise_price":72.94,"expiration_date":"2034-03-20","underlying":"Common Shares","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0000950170-24-035515","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024035515/ownership.xml","form_type":"4"}},{"id":1572384,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-18T21:45:09.000Z","date":"2024-03-15","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on December 1, 2017 with respect to 260,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning January 1, 2018."}],"balance_after":19582,"derivative":{"exercise_price":19.12,"expiration_date":"2027-12-01","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-24-032989","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024032989/ownership.xml","form_type":"4"}},{"id":1572383,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-03-18T21:45:09.000Z","date":"2024-03-15","kind":"sale","planned":true,"acquired":false,"shares":9387,"price":73.0604,"value":685817.9748,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.47 to $73.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":208122,"source":{"system":"sec-edgar","filing":"0000950170-24-032989","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024032989/ownership.xml","form_type":"4"}},{"id":1572382,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-03-18T21:45:09.000Z","date":"2024-03-15","kind":"sale","planned":true,"acquired":false,"shares":10613,"price":71.9693,"value":763810.1809,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.47 to $72.445, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":217509,"source":{"system":"sec-edgar","filing":"0000950170-24-032989","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024032989/ownership.xml","form_type":"4"}},{"id":1572381,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-03-18T21:45:09.000Z","date":"2024-03-15","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":19.12,"value":382400.0,"ownership":{"direct":true},"balance_after":228122,"source":{"system":"sec-edgar","filing":"0000950170-24-032989","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024032989/ownership.xml","form_type":"4"}},{"id":1581107,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-12T21:45:08.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":false,"shares":9000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This restricted stock unit award was granted on March 11, 2021 with respect to 36,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This restricted stock unit award was granted on March 11, 2021 with respect to 36,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025."}],"balance_after":9000,"derivative":{"underlying":"Common Shares","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000950170-24-030189","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024030189/ownership.xml","form_type":"4"}},{"id":1581106,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-12T21:45:08.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":false,"shares":19250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on March 10, 2023 with respect to 77,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on March 10, 2023 with respect to 77,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027."}],"balance_after":57750,"derivative":{"underlying":"Common Shares","underlying_shares":19250},"source":{"system":"sec-edgar","filing":"0000950170-24-030189","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024030189/ownership.xml","form_type":"4"}},{"id":1581105,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-03-12T21:45:08.000Z","date":"2024-03-12","kind":"sale","planned":false,"acquired":false,"shares":4583,"price":74.44,"value":341158.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":208122,"source":{"system":"sec-edgar","filing":"0000950170-24-030189","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024030189/ownership.xml","form_type":"4"}},{"id":1581104,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-03-12T21:45:08.000Z","date":"2024-03-11","kind":"exercise","planned":false,"acquired":true,"shares":9000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":212705,"source":{"system":"sec-edgar","filing":"0000950170-24-030189","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024030189/ownership.xml","form_type":"4"}},{"id":1581103,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-03-12T21:45:08.000Z","date":"2024-03-11","kind":"sale","planned":false,"acquired":false,"shares":9802,"price":78.26,"value":767104.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":203705,"source":{"system":"sec-edgar","filing":"0000950170-24-030189","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024030189/ownership.xml","form_type":"4"}},{"id":1581102,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-03-12T21:45:08.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":true,"shares":19250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":213507,"source":{"system":"sec-edgar","filing":"0000950170-24-030189","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024030189/ownership.xml","form_type":"4"}},{"id":1629310,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-02-21T22:45:17.000Z","date":"2024-02-18","kind":"exercise","planned":false,"acquired":false,"shares":13250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 53,000 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on February 18, 2022 with respect to 53,000 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026."}],"balance_after":26500,"derivative":{"underlying":"Common Shares","underlying_shares":13250},"source":{"system":"sec-edgar","filing":"0000950170-24-018174","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024018174/ownership.xml","form_type":"4"}},{"id":1629309,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-02-21T22:45:17.000Z","date":"2024-02-20","kind":"sale","planned":false,"acquired":false,"shares":6370,"price":79.67,"value":507497.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":194257,"source":{"system":"sec-edgar","filing":"0000950170-24-018174","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024018174/ownership.xml","form_type":"4"}},{"id":1629308,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-02-21T22:45:17.000Z","date":"2024-02-18","kind":"exercise","planned":false,"acquired":true,"shares":13250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":200627,"source":{"system":"sec-edgar","filing":"0000950170-24-018174","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024018174/ownership.xml","form_type":"4"}},{"id":1638284,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-16T22:45:12.000Z","date":"2024-02-15","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on December 1, 2017 with respect to 260,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning January 1, 2018."}],"balance_after":39582,"derivative":{"exercise_price":19.12,"expiration_date":"2027-12-01","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-24-016574","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024016574/ownership.xml","form_type":"4"}},{"id":1638283,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-02-16T22:45:12.000Z","date":"2024-02-15","kind":"sale","planned":true,"acquired":false,"shares":1100,"price":81.6645,"value":89830.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.55 to $81.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":187377,"source":{"system":"sec-edgar","filing":"0000950170-24-016574","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024016574/ownership.xml","form_type":"4"}},{"id":1638282,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-02-16T22:45:12.000Z","date":"2024-02-15","kind":"sale","planned":true,"acquired":false,"shares":5951,"price":81.0379,"value":482256.5429,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.55 to $81.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":188477,"source":{"system":"sec-edgar","filing":"0000950170-24-016574","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024016574/ownership.xml","form_type":"4"}},{"id":1638281,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-02-16T22:45:12.000Z","date":"2024-02-15","kind":"sale","planned":true,"acquired":false,"shares":12949,"price":79.9359,"value":1035089.9691,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.40 to $80.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":194428,"source":{"system":"sec-edgar","filing":"0000950170-24-016574","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024016574/ownership.xml","form_type":"4"}},{"id":1638280,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-02-16T22:45:12.000Z","date":"2024-02-15","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":19.12,"value":382400.0,"ownership":{"direct":true},"balance_after":207377,"source":{"system":"sec-edgar","filing":"0000950170-24-016574","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024016574/ownership.xml","form_type":"4"}},{"id":1665208,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-31T22:45:05.000Z","date":"2024-01-29","kind":"exercise","planned":true,"acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This performance-based stock option was granted on December 1, 2017 with respect to 150,000 Common Shares and was subject to both time- and performance-based vesting. Performance-based stock options vested as to 112,500 options on December 1, 2020 and 37,500 options on December 1, 2021, based on the Company's performance over the applicable performance period, and subject to the terms and conditions of the agreement evidencing the award and the Company's 2016 Stock Option and Incentive Plan."}],"balance_after":100000,"derivative":{"exercise_price":19.12,"expiration_date":"2027-12-01","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-009505","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024009505/ownership.xml","form_type":"4"}},{"id":1665207,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-01-31T22:45:05.000Z","date":"2024-01-29","kind":"sale","planned":true,"acquired":false,"shares":700,"price":61.0998,"value":42769.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $61.04 to $61.155, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":187377,"source":{"system":"sec-edgar","filing":"0000950170-24-009505","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024009505/ownership.xml","form_type":"4"}},{"id":1665206,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-01-31T22:45:05.000Z","date":"2024-01-29","kind":"sale","planned":true,"acquired":false,"shares":49300,"price":60.5031,"value":2982802.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2023"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $60.04 to $61.02, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":188077,"source":{"system":"sec-edgar","filing":"0000950170-24-009505","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024009505/ownership.xml","form_type":"4"}},{"id":1665205,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":34821,"kind":"person","name":"Kulkarni Samarth","position":1,"cik":"0001682019","reported_name":"Kulkarni Samarth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-01-31T22:45:05.000Z","date":"2024-01-29","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":19.12,"value":956000.0,"ownership":{"direct":true},"balance_after":237377,"source":{"system":"sec-edgar","filing":"0000950170-24-009505","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024009505/ownership.xml","form_type":"4"}}],"next_cursor":"2024-01-31T22:45:05.000000Z,1665205"}